Indication
Skin Tumor
6 clinical trials
9 products
Clinical trial
A Phase I Open-Label, Dose Escalation Study of the Safety and Tolerability of ANK-101 in Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-07-01
Product
ANK-101Clinical trial
A Phase 1/2, Open-Label Study to Investigate the Safety and Efficacy of Membrane Bound IL15 Expressing Tumor-Infiltrating Lymphocytes (OBX-115) In Participants With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-10-30
Product
OBX-115Clinical trial
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of JCXH-211 Intratumoral Injection in Patients With Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2025-07-24
Product
JCXH-211Clinical trial
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of JCXH-211 Intratumoral Injection in Patients With Malignant Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2024-03-01
Clinical trial
Topical Anaesthesia in Cutaneous Head and Neck Surgery: a Randomized Controlled TrialStatus: Completed, Estimated PCD: 2023-07-07
Product
EMLAProduct
Ethyl chlorideProduct
Aqueous creamClinical trial
A Single Arm Phase 2 Study of Talimogene Laherparepvec in Patients With Cutaneous Squamous Cell CancerStatus: Completed, Estimated PCD: 2023-07-19
Product
TVEC InjectionProduct
TVEC injectionProduct
TVEC